The cost hike of the antidepressant, first reported on April 3, sets the price of a 120-milliliter bottle at $67.
The company also raised the price of a generic version of Vicodin and haloperidol, a schizophrenia treatment, by more than 100 percent, according to the report.
While triple-digit price hikes are not illegal, they are a rebuke of a common industry practice of keeping price increases below 10 percent annually.
Read the full report here.
More articles on pharmacy:
7 drugs projected to become blockbusters by 2023
3 insulin manufacturers to testify at House panel April 10
Cigna-Express Scripts cap out-of-pocket 30-day insulin costs at $25
